Skip to main content

High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma

Publication ,  Conference
Saglam, O; Cao, B; Wang, X; Toruner, G; Conejo-Garcia, J
Published in: LABORATORY INVESTIGATION
2021

Duke Scholars

Published In

LABORATORY INVESTIGATION

EISSN

1530-0307

ISSN

0023-6837

Publication Date

2021

Volume

101

Issue

SUPPL 1

Start / End Page

743 / 743

Related Subject Headings

  • Pathology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Saglam, O., Cao, B., Wang, X., Toruner, G., & Conejo-Garcia, J. (2021). High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma. In LABORATORY INVESTIGATION (Vol. 101, pp. 743–743).
Saglam, Ozlen, Biwei Cao, Xuefeng Wang, Gokce Toruner, and Jose Conejo-Garcia. “High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma.” In LABORATORY INVESTIGATION, 101:743–743, 2021.
Saglam O, Cao B, Wang X, Toruner G, Conejo-Garcia J. High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma. In: LABORATORY INVESTIGATION. 2021. p. 743–743.
Saglam, Ozlen, et al. “High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma.” LABORATORY INVESTIGATION, vol. 101, no. SUPPL 1, 2021, pp. 743–743.
Saglam O, Cao B, Wang X, Toruner G, Conejo-Garcia J. High BRD4 Expression is an Independent Prognostic Factor in Endometrial Carcinoma. LABORATORY INVESTIGATION. 2021. p. 743–743.

Published In

LABORATORY INVESTIGATION

EISSN

1530-0307

ISSN

0023-6837

Publication Date

2021

Volume

101

Issue

SUPPL 1

Start / End Page

743 / 743

Related Subject Headings

  • Pathology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences